Cargando…
Evaluation of a newly developed quantitative determination kit for tumor marker CA15‐3 with chemiluminescent assay
BACKGROUND: Tumor marker carbohydrate antigen 15‐3 (CA15‐3) is used as a biomarker to aid to diagnose and monitor the prognosis of breast cancer patients. A new quantitative determination kit for CA15‐3 with chemiluminescent assay was developed by Xiamen InnoDx Biotech Co., Ltd, China. Therefore, we...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811926/ https://www.ncbi.nlm.nih.gov/pubmed/28233344 http://dx.doi.org/10.1002/jcla.22158 |